Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | S100A4 | P26447 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.37 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.37 |
| ▸ | BCL2 | P10415 | 1/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.36 |
| ▸ | TDP2 | O95551 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23221362 | 0.90 | PDK2 (0.44) | PDK2CA1CA2CA4CA7 | |
| SCHEMBL16852578 | 0.90 | PDK2 (0.60) | PDK2CA1CA2CA4CA7 | |
| SCHEMBL2484540 | 0.86 | PDK2 (0.50) | PDK2CA1CA2CA4CA7 | |
| SCHEMBL1891712 | 0.86 | PDK2 (0.50) | PDK2CA1CA2CA4CA7 | |
| SCHEMBL14099590 | 0.84 | PDK2 (0.39) | PDK2CA1CA2CA4CA7 | |
| SCHEMBL4241290 | 0.82 | PDK2 (0.41) | PDK2CA1CA2CA4CA7 | |
| SCHEMBL204806 | 0.81 | PDK2 (0.44) | PDK2CA1CA2CA4CA7 | |
| SCHEMBL29587737 | 0.81 | PDK2 (0.44) | PDK2CA1CA2CA4CA7 | |
| SCHEMBL17430723 | 0.81 | PDK2 (0.44) | PDK2CA1CA2CA4CA7 | |
| SCHEMBL19116324 | 0.81 | PDK2 (0.44) | PDK2CA1CA2CA4CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11472901-B2 | Polymer, coating composition comprising same, and organic light-emitting device using same | LG CHEM, LTD. | 2022-10-18 | — | — | US | disclosed |
| US-11374175-B2 | Polymer, coating composition comprising same, and organic light-emitting device using same | LG CHEM, LTD. | 2022-06-28 | — | — | US | disclosed |
| EP-2597932-B1 | MANUFACTURING METHOD FOR ORGANIC LIGHT-EMITTING DEVICE | SUMITOMO CHEMICAL CO (JP) | 2021-04-14 | — | — | EP | disclosed |
| EP-2680672-B1 | METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2021-03-31 | — | — | EP | disclosed |
| US-20200239610-A1 | Polymer, Coating Composition Comprising Same, and Organic Light-Emitting Device Using Same | LG CHEM, LTD. (KR) | 2020-07-30 | — | — | US | disclosed |
| US-20200235301-A1 | Polymer, Coating Composition Comprising Same, and Organic Light-Emitting Device Using Same | LG CHEM, LTD. (KR) | 2020-07-23 | — | — | US | disclosed |
| EP-2692796-B1 | COMPOSITION | SUMITOMO CHEMICAL CO (JP) | 2019-07-10 | — | — | EP | disclosed |
| EP-2597933-B1 | MANUFACTURING METHOD FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2019-06-12 | — | — | EP | disclosed |
| US-20170253614-A1 | HEPATITIS C VIRUS INHIBITORS AND USES THEREOF IN PREPARATION OF DRUGS | CHANGZHOU YINSHENG PHARMACEUTICAL CO., LTD. (CN) | 2017-09-07 | — | — | US | disclosed |
| US-20170253614-A1 | HEPATITIS C VIRUS INHIBITORS AND USES THEREOF IN PREPARATION OF DRUGS | CHANGZHOU YINSHENG PHARMACEUTICAL CO., LTD. (CN) | 2017-09-07 | — | — | US | disclosed |
| US-20130183782-A1 | METHOD FOR PRODUCING ORGANIC EL ELEMENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-07-18 | — | — | US | disclosed |
| EP-2597696-A1 | ORGANIC EL ELEMENT | Sumitomo Chemical Company Limited (JP) | 2013-05-29 | — | — | EP | disclosed |
| EP-2597932-A1 | MANUFACTURING METHOD FOR ORGANIC LIGHT-EMITTING DEVICE, AND ORGANIC LIGHT-EMITTING DEVICE | Sumitomo Chemical Company, Limited (JP) | 2013-05-29 | — | — | EP | disclosed |
| EP-2597934-A1 | METHOD FOR PRODUCING ORGANIC EL ELEMENT | Sumitomo Chemical Company, Limited (JP) | 2013-05-29 | — | — | EP | disclosed |
| EP-2597933-A1 | MANUFACTURING METHOD FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | Sumitomo Chemical Company, Limited (JP) | 2013-05-29 | — | — | EP | disclosed |
| US-20130122625-A1 | METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENT ELEMENT | SUMITOMO CHEMICAL CO., LTD. (JP) | 2013-05-16 | — | — | US | disclosed |
| US-20130122625-A1 | METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENT ELEMENT | SUMITOMO CHEMICAL CO., LTD. (JP) | 2013-05-16 | — | — | US | disclosed |
| US-20130112966-A1 | METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-05-09 | — | — | US | disclosed |
| US-20130112966-A1 | METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-05-09 | — | — | US | disclosed |
| WO-2012011510-A1 | ORGANIC EL ELEMENT | 住友化学株式会社 (JP) | 2012-01-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170253614-A1 | HEPATITIS C VIRUS INHIBITORS AND USES THEREOF IN PREPARATION OF DRUGS | HAVCR2, HCCS, LIPC | PDK2 2422/4885CA1 4836/4885CA2 4707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.